Empiece
mlrnview

Risking 1.5% in Dr LAL PATH LABS for the reward of 7.5%

Largo
DR LAL PATHLABS LTD (NSE:LALPATHLAB)  
mlrnview  
NSE:LALPATHLAB   DR LAL PATHLABS LTD
Trend Analysis Beyond Technical Analysis longtrade drlalpathlab SMC bullishsetup
1
0
trendanalysis beyondta longtrade drlalpathlab smc bullishsetup
Dr Lal PathLabs net profit zooms 54% to Rs 81.3 crore in Q3. Yet the stock is consolidating in the same place for a week, even CNXPHARMA is trading at the ATH. This might be a very good chance to enter at below price of 2400 (2394) with 1.5% stoploss.

Ideas relacionadas

mlrnview
REVERSAL on EICHER MOTORS with R:R of 6.5
mlrnview
expecting a clean fall in AXIS BANK
mlrnview
EXPECT 8% RETURN FROM INDIA's LARGEST CEMENT PRODUERS
mlrnview
RISKING 3% FOR THE REWARD OF 15% IN NSE:METROPOLIS HEALTHCARE
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.